Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Barrett Esophagus-I: Introduction01:21

Barrett Esophagus-I: Introduction

1.1K
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
1.1K
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

1.4K
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.4K
Upper GI Series: Barium Swallow01:24

Upper GI Series: Barium Swallow

2.1K
The Barium Swallow Study, or a Barium Esophagogram, is a diagnostic imaging method used to visualize the upper gastrointestinal (GI) tract, including the esophagus, stomach, and small intestine. It employs barium sulfate, a radiopaque contrast material, to provide clear images of the upper digestive system, helping to identify abnormalities, diseases, or structural issues.
Purpose and Procedure
Patients undergoing this procedure ingest a liquid containing barium sulfate with a chalky...
2.1K
Endoscopic Procedures I: Esophagogastroduodenoscopy01:29

Endoscopic Procedures I: Esophagogastroduodenoscopy

1.7K
An Esophagogastroduodenoscopy (EGD) is a diagnostic procedure in which an endoscopist uses a flexible, lighted endoscope to visualize the upper gastrointestinal (GI) tract. The procedure includes visualizing the oropharynx, esophagus, stomach, and the first part of the small intestine, the duodenum.
During an EGD, the endoscope can be used to:
1.7K
Esophageal Strictures-II: Clinical Features and Management01:26

Esophageal Strictures-II: Clinical Features and Management

841
Patients with esophageal strictures often experience a range of symptoms. Initially, they may have difficulty swallowing solid foods, which can progress to include liquids. Additional symptoms may involve chest pain or discomfort, regurgitating food and fluids, heartburn, unintentional weight loss, coughing or choking during meals, and hoarseness.
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
841
Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

1.1K
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of recurrent esophageal strictures with a paclitaxel-coated balloon dilator: initial United States experience.

Gastrointestinal endoscopy·2026
Same author

Development and initial clinical experience with a paclitaxel-coated balloon for the treatment of benign difficult esophageal strictures.

iGIE : innovation, investigation and insights·2026
Same author

Colibactin-producing <i>E. coli</i> promote carcinogenesis of gastroesophageal adenocarcinoma and simultaneously induce autophagy and differentiation.

bioRxiv : the preprint server for biology·2025
Same author

Increased reflux secondary bile acids are associated with changes to the microbiome and transcriptome in Barrett's esophagus.

Gut microbes·2025
Same author

Photodynamic priming with red light triggers adaptive immune responses in a pancreatic cancer mouse model.

Journal of photochemistry and photobiology. B, Biology·2025
Same author

Position statement of the World Endoscopy Organization: Role of endoscopy in screening, diagnosis, and treatment of esophageal superficial squamous neoplasiaia.

Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society·2024

Related Experiment Video

Updated: Mar 12, 2026

Diagnosis of Neoplasia in Barrett&#8217;s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

12.5K

Screening for Barrett's esophagus.

Liam Zakko1, Lori Lutzke1, Kenneth K Wang2

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

Minerva Medica
|October 30, 2016
PubMed
Summary
This summary is machine-generated.

Screening for Barrett

More Related Videos

An Immunofluorescent Method for Characterization of Barrett&#8217;s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.5K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

888

Related Experiment Videos

Last Updated: Mar 12, 2026

Diagnosis of Neoplasia in Barrett&#8217;s Esophagus using Vital-dye Enhanced Fluorescence Imaging
06:55

Diagnosis of Neoplasia in Barrett’s Esophagus using Vital-dye Enhanced Fluorescence Imaging

Published on: May 11, 2014

12.5K
An Immunofluorescent Method for Characterization of Barrett&#8217;s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.5K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

888

Area of Science:

  • Gastroenterology and Oncology
  • Esophageal Cancer Research

Background:

  • Barrett's esophagus is the sole known precursor to esophageal adenocarcinoma.
  • Screening for Barrett's esophagus is debated, with unclear implementation strategies.

Purpose of the Study:

  • To discuss the definition of Barrett's esophagus.
  • To review evidence on the cost-effectiveness of screening and surveillance.
  • To examine risk factors, screening techniques, and emerging technologies.

Main Methods:

  • Literature review of current definitions and evidence.
  • Analysis of risk factors for Barrett's esophagus and esophageal adenocarcinoma.
  • Evaluation of standard and novel screening technologies.

Main Results:

  • Evidence suggests screening and surveillance may be cost-effective in preventing esophageal adenocarcinoma.
  • Identifies key risk factors for targeted screening.
  • Highlights limitations of current methods and potential of new technologies.

Conclusions:

  • Barrett's esophagus screening is crucial for preventing esophageal adenocarcinoma.
  • Further research into optimal implementation and new technologies is warranted.
  • Cost-effectiveness data supports targeted screening and surveillance programs.